1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of NephrolithiasisGalina Nesterova, William A. Gahl, May Christine V. Malicdan et al.|Clinical Journal of the American Society of Nephrology|2013Cited by 153
Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline ModelHeather Gray‐Edwards, Douglas R. Martin, Yvonne L. Latour et al.|Molecular Therapy|2017Cited by 58
MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosisDebra S. Regier, Cynthia J. Tifft, Hyuk‐Joon Kwon et al.|American Journal of Medical Genetics Part A|2015Cited by 41